Physiomics (LON:PYC) Stock Price Down 6.4% – What’s Next?

Physiomics Plc (LON:PYC)’s share price fell 6.4% during mid-day trading on Tuesday . The stock traded as low as GBX 0.38 ($0.01) and last traded at GBX 0.40 ($0.01). 3,171,313 shares changed hands during trading, a decline of 42% from the average session volume of 5,487,729 shares. The stock had previously closed at GBX 0.43 ($0.01).

Physiomics Stock Performance

The company’s fifty day simple moving average is GBX 0.45 and its 200-day simple moving average is GBX 0.44. The company has a market capitalization of £1.21 million, a P/E ratio of -2.34 and a beta of 1.69.

Physiomics (LON:PYC) last issued its earnings results on Monday, September 29th. The company reported GBX (0.17) earnings per share (EPS) for the quarter. Physiomics had a negative return on equity of 127.68% and a negative net margin of 106.80%. On average, sell-side analysts predict that Physiomics Plc will post -0.13 EPS for the current year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.